#car-t

[ follow ]
#ai-in-biotech #cell-therapy-manufacturing #cell-imaging #multiple-myeloma #immunotherapy
Healthcare
fromFortune
4 hours ago

This U.K. startup's AI platform could slash the cost of CAR-T therapy and other cell-based medicines | Fortune

AI predicts future health and performance of human cells from microscope images, enabling selection of optimal cells and reducing cost and waste in cell-based therapies.
Cancer
fromFast Company
3 months ago

Why a rare blood cancer has become a testing ground for cancer drug innovation

Multiple myeloma drives advanced gene and antibody therapies, transforming cancer into a chronic, high-cost condition while extending patient survival.
[ Load more ]